Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries for receptors.
Fig. 1. The sreening workflow of Receptor.AI
This includes comprehensive molecular simulations of the receptor in its native membrane environment, paired with ensemble virtual screening that factors in its conformational mobility. In cases involving dimeric or oligomeric receptors, the entire functional complex is modelled, pinpointing potential binding pockets on and between the subunits to capture the full range of mechanisms of action.
Key features that set our library apart include:
partner
Reaxense
upacc
P30542
UPID:
AA1R_HUMAN
Alternative names:
-
Alternative UPACC:
P30542; A6NFY5; A6NGP4; A8K1L3; B3KXQ4; D2CGD0; Q6FHK3; Q8TAM8
Background:
The Adenosine receptor A1 plays a pivotal role in cellular signaling as a receptor for adenosine. It operates through G proteins that inhibit adenylyl cyclase, impacting various physiological processes. This receptor's intricate mechanism of action underscores its significance in the realm of molecular biology and pharmacology.
Therapeutic significance:
Understanding the role of Adenosine receptor A1 could open doors to potential therapeutic strategies. Its involvement in cellular signaling pathways offers a promising avenue for the development of novel treatments targeting a range of conditions.